Ricardo Mingarini Terra

Ricardo Mingarini Terra

Auto-generated profile, based on publicly available information

Ricardo Mingarini Terra

Thoracic Surgery Division, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
RTRicardo Mingarini Terra
Ricardo Mingarini Terra
HMHélio Minamoto
Hélio Minamoto
FCFelipe Carneiro
Felipe Carneiro
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
FJFábio Biscegli Jatene
Fábio Biscegli Jatene

1 February 2018 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
LALuiz Henrique Araujo
Luiz Henrique Araujo
CBClarissa Baldotto
Clarissa Baldotto
GJGilberto de Castro Jr
Gilberto de Castro Jr
AKArtur Katz
Artur Katz
CFCarlos Gil Ferreira
Carlos Gil Ferreira
CBCarlos Barrios
Carlos Barrios
Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.

1 August 2009 in Chest
Verified
Journal Article
Closed access
RTRicardo Mingarini Terra
Ricardo Mingarini Terra
JJJader Joel Machado Junqueira
Jader Joel Machado Junqueira
LTLisete Ribeiro Teixeira
Lisete Ribeiro Teixeira
FVFrancisco Suso Vargas
Francisco Suso Vargas
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
FJFáabio Biscegli Jatene
Fáabio Biscegli Jatene

1 January 2020 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Closed access
PDF file
VFViviane Rossi Figueiredo
Viviane Rossi Figueiredo
PCPaulo Francisco Guerreiro Cardoso
Paulo Francisco Guerreiro Cardoso
MJMarcia Jacomelli
Marcia Jacomelli
LSLília Maia Santos
Lília Maia Santos
MMMauricio Minata
Mauricio Minata
RTRicardo Mingarini Terra
Ricardo Mingarini Terra
Lung cancer (LC) is one of the leading causes of death worldwide. Accurate mediastinal staging is mandatory in order to assess prognosis and to select patients for surgical treatment. EBUS-TBNA is a minimally invasive procedure that allows sampling of mediastinal lymph nodes (LNs). Some studies have suggested that EBUS-TBNA is preferable to surgical mediastinoscopy for mediastinal staging of LC. The objective of this systematic review and meta-analysis was to compare EBUS-TBNA and mediastinoscopy in terms of their effectiveness for mediastinal LN staging in potentially operable non-small cell lung cancer (NSCLC). This was a systematic review and meta-analysis, in which we searched various databases. We included studies comparing the accuracy of EBUS-TBNA with that of mediastinoscopy for mediastinal LN staging in patients with NSCLC. In the meta-analysis, we calculated sensitivity, specificity, positive likelihood ratios, and negative likelihood ratios. We also analyzed the risk difference for the reported complications associated with each procedure. The search identified 4,201 articles, 5 of which (with a combined total of 532 patients) were selected for inclusion in the meta-analysis. There were no statistically significant differences between EBUS-TBNA and mediastinoscopy in terms of the sensitivity (81% vs. 75%), specificity (100% for both), positive likelihood ratio (101.03 vs. 95.70), or negative likelihood ratio (0.21 vs. 0.23). The area under the summary ROC curve was 0.9881 and 0.9895 for EBUS-TBNA and mediastinoscopy, respectively. Although the number of complications was higher for mediastinoscopy, the difference was not significant (risk difference: -0.03; 95% CI: -0.07 to 0.01; I2 = 76%). EBUS-TBNA and mediastinoscopy produced similar results for mediastinal staging of NSCLC. EBUS-TBNA can be the procedure of first choice for LN staging in patients with NSCLC.

1 October 2021 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
RTRicardo Mingarini Terra
Ricardo Mingarini Terra
PLPedro Henrique Cunha Leite
Pedro Henrique Cunha Leite
AVAlberto Jorge Monteiro Dela Vega
Alberto Jorge Monteiro Dela Vega
Global status of the robotic thoracic surgery Ricardo Mingarini Terra, Pedro Henrique Cunha Leite, Alberto Jorge Monteiro Dela Vega

31 August 2022 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
RTRicardo Mingarini Terra1A
Ricardo Mingarini Terra1A
PAPedro Henrique Xavier Nabuco de Araujo1A
Pedro Henrique Xavier Nabuco de Araujo1A
LLLeticia Leone Lauricella1A
Leticia Leone Lauricella1A
JCJose Ribas Milanese de Campos1A
Jose Ribas Milanese de Campos1A
JTJuliana Rocha Mol Trindade1A
Juliana Rocha Mol Trindade1A
PPPaulo Manuel Pêgo-Fernandes
Paulo Manuel Pêgo-Fernandes
Objective: To compare 90-day morbidity in patients undergoing lung lobectomy performed by either robotic-assisted thoracic surgery (RATS) or video-assisted thoracic surgery (VATS). Intraoperative complications, drainage time, length of hospital stay, postoperative pain, postoperative quality of life, and readmissions within 90 days were also compared. Methods: This was a two-arm randomized clinical trial including patients with lung lesions (primary lung cancer or lung metastasis) who were candidates for lung lobectomy. Patients with comorbidities that precluded surgical treatment were excluded. All patients followed the same postoperative protocol. Results: The overall sample comprised 76 patients (39 in the VATS group and 37 in the RATS group). The two groups were similar regarding gender, age, BMI, FEV1 in % of predicted, and comorbidities. Postoperative complications within 90 days tended to be more common in the VATS group than in the RATS group, but the difference was not significant (p = 0.12). However, when only major complications were analyzed, this tendency disappeared (p = 0.58). Regarding postoperative outcomes, the VATS group had a significantly higher number of readmissions within 90 days than did the RATS group (p = 0.029). No significant differences were found regarding intraoperative complications, drainage time, length of hospital stay, postoperative pain, and postoperative quality of life. Conclusions: RATS and VATS lobectomy had similar 90-day outcomes. However, RATS lobectomy was associated with a significant reduction in the 90-day hospital readmission rate. Larger studies are necessary to confirm such a finding. (ClinicalTrials.gov identifier: NCT02292914 [http://www.clinicaltrials.gov/])